Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,396 | -2,260 | -2,297 | -3,105 | -1,264 |
| Depreciation Amortization | 93 | 256 | 186 | 432 | 206 |
| Accounts receivable | -1 | 237 | -263 | -31 | -26 |
| Other Working Capital | 482 | 829 | 579 | 613 | 310 |
| Other Operating Activity | 106 | 402 | 1,115 | 1,324 | 460 |
| Operating Cash Flow | $-715 | $-537 | $-680 | $-767 | $-315 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -8 | -5 | -53 | -17 |
| Purchase Sale Intangibles | -7 | -13 | -41 | -12 | -46 |
| Other Investing Activity | -7 | -13 | -41 | -12 | -46 |
| Investing Cash Flow | $-7 | $-21 | $-46 | $-65 | $-63 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 829 | 100 | 607 | 191 | 13 |
| Common Stock Issued | N/A | 560 | 225 | 701 | 327 |
| Other Financing Activity | -55 | -178 | -43 | -37 | 34 |
| Financing Cash Flow | $774 | $483 | $788 | $855 | $374 |
| Beginning Cash Position | 24 | 100 | 37 | 13 | 17 |
| End Cash Position | 76 | 24 | 100 | 37 | 13 |
| Net Cash Flow | $52 | $-75 | $63 | $24 | $-4 |
| Free Cash Flow | |||||
| Operating Cash Flow | -715 | -537 | -680 | -767 | -315 |
| Capital Expenditure | N/A | -8 | -5 | -53 | -17 |
| Free Cash Flow | -715 | -545 | -685 | -819 | -332 |